An association between maternal weight change in the year before pregnancy and infant birth weight: ELFE, a French national birth cohort study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
08 2019
Historique:
received: 06 03 2019
accepted: 17 07 2019
entrez: 21 8 2019
pubmed: 21 8 2019
medline: 10 1 2020
Statut: epublish

Résumé

Weight-control interventions in pregnant women with overweight or obesity have limited effectiveness for fetal growth and birth outcomes. Interventions or prevention programs aiming at the pre-pregnancy period should be considered. However, how the woman's weight change before pregnancy affects fetal growth is not known. We investigated the association between weight change over the year before pregnancy and birth weight. We used the inclusion data of 16,395 women from the ELFE French national birth cohort, a nationally representative cohort in which infants were enrolled at birth with their families in 2011. Maternal weight change was self-reported and classified into 3 groups: moderate weight variation or stable weight, weight loss > 5 kg, and weight gain > 5 kg or both weight loss and gain > 5 kg. Multiple linear regression models were used to investigate the association between pre-pregnancy weight change and a birth weight z-score calculated according to the French Audipog reference, adjusted for a large set of maternal characteristics. The analyses were stratified by maternal body mass index (BMI) at conception (<25 versus ≥25 kg/m2) and adjusted for BMI within these categories. We used the MacKinnon method to test the mediating effect of gestational weight gain (GWG) on these associations. Mother's mean age was 30.5 years, 87% were born in France, and 26% had overweight or obesity. For women in either BMI category at conception, GWG was more than 2 kg higher, on average, for women with weight loss before pregnancy than for women with stable weight or moderate weight variation. For women with BMI < 25 kg/m2 at conception, birth weight was significantly higher with weight loss than stable weight before pregnancy (β = 0.08 [95% CI 0.02; 0.14], p = 0.01), and this total effect was explained by a significant mediating effect through GWG. For women with BMI ≥ 25 kg/m2 at conception, birth weight was not associated with pre-pregnancy weight loss during the year before pregnancy. Mediation analysis revealed that in these women, the direct effect of pre-pregnancy weight loss that would have resulted in a smaller birth weight z-score (β = -0.11 [95% CI -0.19; -0.03], p = 0.01) was cancelled out by the GWG. The mediating effect of GWG was even higher when weight loss resulted from a restrictive diet in the year before pregnancy. Weight gain before pregnancy was not associated with birth weight. Although we included a large number of women and had extensive data, the only potential cause of pre-pregnancy weight loss that was investigated was dieting for intentional weight loss. We have no information on other potential causes but did however exclude women with a history of pre-pregnancy chronic disease. Another limitation is declaration bias due to self-reported data. Health professionals should be aware that GWG may offset the expected effect of weight loss before conception on fetal growth in overweight and obese women. Further studies are required to understand the underlying mechanisms in order to develop weight-control interventions and improve maternal periconceptional health and developmental conditions for the fetus.

Sections du résumé

BACKGROUND
Weight-control interventions in pregnant women with overweight or obesity have limited effectiveness for fetal growth and birth outcomes. Interventions or prevention programs aiming at the pre-pregnancy period should be considered. However, how the woman's weight change before pregnancy affects fetal growth is not known. We investigated the association between weight change over the year before pregnancy and birth weight.
METHODS AND FINDINGS
We used the inclusion data of 16,395 women from the ELFE French national birth cohort, a nationally representative cohort in which infants were enrolled at birth with their families in 2011. Maternal weight change was self-reported and classified into 3 groups: moderate weight variation or stable weight, weight loss > 5 kg, and weight gain > 5 kg or both weight loss and gain > 5 kg. Multiple linear regression models were used to investigate the association between pre-pregnancy weight change and a birth weight z-score calculated according to the French Audipog reference, adjusted for a large set of maternal characteristics. The analyses were stratified by maternal body mass index (BMI) at conception (<25 versus ≥25 kg/m2) and adjusted for BMI within these categories. We used the MacKinnon method to test the mediating effect of gestational weight gain (GWG) on these associations. Mother's mean age was 30.5 years, 87% were born in France, and 26% had overweight or obesity. For women in either BMI category at conception, GWG was more than 2 kg higher, on average, for women with weight loss before pregnancy than for women with stable weight or moderate weight variation. For women with BMI < 25 kg/m2 at conception, birth weight was significantly higher with weight loss than stable weight before pregnancy (β = 0.08 [95% CI 0.02; 0.14], p = 0.01), and this total effect was explained by a significant mediating effect through GWG. For women with BMI ≥ 25 kg/m2 at conception, birth weight was not associated with pre-pregnancy weight loss during the year before pregnancy. Mediation analysis revealed that in these women, the direct effect of pre-pregnancy weight loss that would have resulted in a smaller birth weight z-score (β = -0.11 [95% CI -0.19; -0.03], p = 0.01) was cancelled out by the GWG. The mediating effect of GWG was even higher when weight loss resulted from a restrictive diet in the year before pregnancy. Weight gain before pregnancy was not associated with birth weight. Although we included a large number of women and had extensive data, the only potential cause of pre-pregnancy weight loss that was investigated was dieting for intentional weight loss. We have no information on other potential causes but did however exclude women with a history of pre-pregnancy chronic disease. Another limitation is declaration bias due to self-reported data.
CONCLUSIONS
Health professionals should be aware that GWG may offset the expected effect of weight loss before conception on fetal growth in overweight and obese women. Further studies are required to understand the underlying mechanisms in order to develop weight-control interventions and improve maternal periconceptional health and developmental conditions for the fetus.

Identifiants

pubmed: 31430274
doi: 10.1371/journal.pmed.1002871
pii: PMEDICINE-D-19-00832
pmc: PMC6701747
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1002871

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
Lancet Diabetes Endocrinol. 2017 Jan;5(1):65-76
pubmed: 27743974
Annu Rev Psychol. 2007;58:593-614
pubmed: 16968208
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
J Gynecol Obstet Biol Reprod (Paris). 1996;25(1):61-70
pubmed: 8901304
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
Am J Obstet Gynecol. 2015 Apr;212(4):502.e1-14
pubmed: 25557209
Diabetes Care. 2008 Jul;31(7):1422-6
pubmed: 18375420
PLoS One. 2013 Apr 16;8(4):e61627
pubmed: 23613888
Matern Child Health J. 2012 Feb;16(2):355-63
pubmed: 21258962
BMJ Open. 2016 May 10;6(5):e010667
pubmed: 27165646
Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
J Pediatr. 2011 Feb;158(2):221-6
pubmed: 20863516
PLoS One. 2014 May 14;9(5):e95132
pubmed: 24827704
Int J Obes (Lond). 2019 Feb;43(2):362-373
pubmed: 30242235
Multivariate Behav Res. 1995 Jan 1;30(1):41
pubmed: 20157641
Clin Sci (Lond). 2013 Feb;124(4):231-41
pubmed: 23126426
Int J Gynaecol Obstet. 2015 Jul;130(1):3-9
pubmed: 25863541
J Obes. 2011;2011:501939
pubmed: 21785717
Paediatr Perinat Epidemiol. 2018 Mar;32(2):152-160
pubmed: 29345321
Eur J Epidemiol. 2011 Oct;26(10):789-96
pubmed: 21710259
Behav Res Methods. 2007 Aug;39(3):384-9
pubmed: 17958149
PLoS One. 2015 Jul 21;10(7):e0132650
pubmed: 26196130
Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77
pubmed: 26165396
Curr Opin Obstet Gynecol. 2009 Dec;21(6):521-6
pubmed: 19809317
BMJ. 2014 Feb 10;348:g1285
pubmed: 24513442
Endocrinology. 2010 Nov;151(11):5195-205
pubmed: 20861234
Am J Obstet Gynecol. 2007 Jun;196(6):530.e1-8
pubmed: 17547882
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023
pubmed: 24239920
BMC Pediatr. 2009 Sep 21;9:58
pubmed: 19772571
J Clin Invest. 2009 Feb;119(2):323-35
pubmed: 19147984
BMC Pregnancy Childbirth. 2014 Jan 22;14:40
pubmed: 24450357
Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):82-9
pubmed: 18226059
Int J Epidemiol. 2011 Feb;40(1):65-101
pubmed: 21097954
JAMA. 2017 Jun 6;317(21):2207-2225
pubmed: 28586887
Obstet Gynecol. 2011 Aug;118(2 Pt 1):305-12
pubmed: 21775846
J Endocrinol. 2001 Nov;171(2):293-8
pubmed: 11691649
Best Pract Res Clin Obstet Gynaecol. 2015 Jan;29(1):133-44
pubmed: 25225055
Lancet. 2018 May 5;391(10132):1830-1841
pubmed: 29673873
Matern Child Health J. 2012 Aug;16(6):1215-23
pubmed: 21735140
J Obes. 2014;2014:204295
pubmed: 24804085
Am J Obstet Gynecol. 2013 Mar;208(3):205.e1-7
pubmed: 23246318
Diabet Med. 2005 Jan;22(1):21-5
pubmed: 15606686

Auteurs

Marion Lecorguillé (M)

Université de Paris, Centre of Research in Epidemiology and Statistics, INSERM, Institut national de la recherche agronomique, Paris, France.

Madalina Jacota (M)

APHP, Unité de Recherche Clinique, Hôpitaux Universitaires Paris île-de-France Ouest, Paris, France.

Blandine de Lauzon-Guillain (B)

Université de Paris, Centre of Research in Epidemiology and Statistics, INSERM, Institut national de la recherche agronomique, Paris, France.

Anne Forhan (A)

Université de Paris, Centre of Research in Epidemiology and Statistics, INSERM, Institut national de la recherche agronomique, Paris, France.

Marie Cheminat (M)

Institut national d'études démographiques, INSERM, Établissement français du sang, Joint Unit Elfe, Paris, France.

Marie-Aline Charles (MA)

Université de Paris, Centre of Research in Epidemiology and Statistics, INSERM, Institut national de la recherche agronomique, Paris, France.
Institut national d'études démographiques, INSERM, Établissement français du sang, Joint Unit Elfe, Paris, France.

Barbara Heude (B)

Université de Paris, Centre of Research in Epidemiology and Statistics, INSERM, Institut national de la recherche agronomique, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH